MA27171A1 - Dihydro-thia-phenanthrene-darbonyl-guanidines, procede de production desdites substances et leur utilisation en tant que medicament ou produit de diagnostic, et medicament contenant lesdites substances - Google Patents
Dihydro-thia-phenanthrene-darbonyl-guanidines, procede de production desdites substances et leur utilisation en tant que medicament ou produit de diagnostic, et medicament contenant lesdites substancesInfo
- Publication number
- MA27171A1 MA27171A1 MA27802A MA27802A MA27171A1 MA 27171 A1 MA27171 A1 MA 27171A1 MA 27802 A MA27802 A MA 27802A MA 27802 A MA27802 A MA 27802A MA 27171 A1 MA27171 A1 MA 27171A1
- Authority
- MA
- Morocco
- Prior art keywords
- substances
- medicament
- darbonyl
- guanidines
- thia
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/10—Dibenzothiopyrans; Hydrogenated dibenzothiopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/10—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms two oxygen atoms and one sulfur atom, e.g. cyclic sulfates
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10204989A DE10204989A1 (de) | 2002-02-07 | 2002-02-07 | Dihydro-thia-phenanthren-carbonyl-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA27171A1 true MA27171A1 (fr) | 2005-01-03 |
Family
ID=27618378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA27802A MA27171A1 (fr) | 2002-02-07 | 2004-07-27 | Dihydro-thia-phenanthrene-darbonyl-guanidines, procede de production desdites substances et leur utilisation en tant que medicament ou produit de diagnostic, et medicament contenant lesdites substances |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP1474414B1 (fr) |
| JP (1) | JP4410564B2 (fr) |
| KR (1) | KR20040096555A (fr) |
| CN (1) | CN1319963C (fr) |
| AR (1) | AR038393A1 (fr) |
| AT (1) | ATE380805T1 (fr) |
| AU (1) | AU2003208337A1 (fr) |
| BR (1) | BR0307495A (fr) |
| CA (1) | CA2475093A1 (fr) |
| CO (1) | CO5601008A2 (fr) |
| DE (2) | DE10204989A1 (fr) |
| HK (1) | HK1073656A1 (fr) |
| HR (1) | HRP20040721A2 (fr) |
| HU (1) | HUP0402595A2 (fr) |
| MA (1) | MA27171A1 (fr) |
| MX (1) | MXPA04007476A (fr) |
| NO (1) | NO20043717L (fr) |
| NZ (1) | NZ534536A (fr) |
| PE (1) | PE20030963A1 (fr) |
| PL (1) | PL370271A1 (fr) |
| RS (1) | RS69204A (fr) |
| RU (1) | RU2306311C2 (fr) |
| TW (1) | TWI268927B (fr) |
| WO (1) | WO2003066620A1 (fr) |
| ZA (1) | ZA200406015B (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200614995A (en) * | 2004-11-10 | 2006-05-16 | Nicholas Piramal India Ltd | Tricyclic guanidine derivatives as sodium-proton exchange inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60262887A (ja) * | 1984-06-11 | 1985-12-26 | Mitsubishi Chem Ind Ltd | 液晶組成物 |
| GB8505756D0 (en) * | 1985-03-06 | 1985-04-11 | Erba Farmitalia | Tricyclic dibenzo condensed derivatives |
| US4948806A (en) * | 1988-03-30 | 1990-08-14 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| DE19601303A1 (de) * | 1996-01-16 | 1997-07-17 | Boehringer Ingelheim Kg | Neuartige Benzoylguanidin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln |
| CA2370607A1 (fr) * | 1999-04-23 | 2000-11-02 | Bristol-Myers Squibb Company | Inhibiteurs d'echange sodium-protons a base de guandines d'acyle bicyclique et procede correspondant |
| DE10001879A1 (de) * | 2000-01-19 | 2001-07-19 | Aventis Pharma Gmbh | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
2002
- 2002-02-07 DE DE10204989A patent/DE10204989A1/de not_active Withdrawn
-
2003
- 2003-01-23 KR KR10-2004-7012241A patent/KR20040096555A/ko not_active Application Discontinuation
- 2003-01-23 RS YU69204A patent/RS69204A/sr unknown
- 2003-01-23 AT AT03706373T patent/ATE380805T1/de not_active IP Right Cessation
- 2003-01-23 EP EP03706373A patent/EP1474414B1/fr not_active Expired - Lifetime
- 2003-01-23 WO PCT/EP2003/000653 patent/WO2003066620A1/fr active IP Right Grant
- 2003-01-23 DE DE50308787T patent/DE50308787D1/de not_active Expired - Lifetime
- 2003-01-23 MX MXPA04007476A patent/MXPA04007476A/es active IP Right Grant
- 2003-01-23 BR BR0307495-1A patent/BR0307495A/pt not_active IP Right Cessation
- 2003-01-23 HU HU0402595A patent/HUP0402595A2/hu unknown
- 2003-01-23 RU RU2004126854/04A patent/RU2306311C2/ru not_active IP Right Cessation
- 2003-01-23 PL PL03370271A patent/PL370271A1/xx not_active Application Discontinuation
- 2003-01-23 AU AU2003208337A patent/AU2003208337A1/en not_active Abandoned
- 2003-01-23 CN CNB038035502A patent/CN1319963C/zh not_active Expired - Fee Related
- 2003-01-23 JP JP2003565993A patent/JP4410564B2/ja not_active Expired - Fee Related
- 2003-01-23 CA CA002475093A patent/CA2475093A1/fr not_active Abandoned
- 2003-01-23 NZ NZ534536A patent/NZ534536A/en unknown
- 2003-01-30 TW TW092102087A patent/TWI268927B/zh not_active IP Right Cessation
- 2003-02-05 AR ARP030100363A patent/AR038393A1/es unknown
- 2003-02-05 PE PE2003000136A patent/PE20030963A1/es not_active Application Discontinuation
-
2004
- 2004-07-27 MA MA27802A patent/MA27171A1/fr unknown
- 2004-07-28 ZA ZA200406015A patent/ZA200406015B/en unknown
- 2004-08-06 HR HR20040721A patent/HRP20040721A2/hr not_active Application Discontinuation
- 2004-08-06 CO CO04076743A patent/CO5601008A2/es not_active Application Discontinuation
- 2004-09-06 NO NO20043717A patent/NO20043717L/no not_active Application Discontinuation
-
2005
- 2005-07-21 HK HK05106161A patent/HK1073656A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PL370271A1 (en) | 2005-05-16 |
| DE10204989A1 (de) | 2003-08-21 |
| NZ534536A (en) | 2006-02-24 |
| HK1073656A1 (en) | 2005-10-14 |
| JP2005517015A (ja) | 2005-06-09 |
| HUP0402595A2 (hu) | 2005-04-28 |
| JP4410564B2 (ja) | 2010-02-03 |
| CN1319963C (zh) | 2007-06-06 |
| PE20030963A1 (es) | 2004-01-12 |
| RS69204A (en) | 2006-12-15 |
| KR20040096555A (ko) | 2004-11-16 |
| HRP20040721A2 (en) | 2005-06-30 |
| RU2004126854A (ru) | 2006-01-27 |
| TWI268927B (en) | 2006-12-21 |
| AR038393A1 (es) | 2005-01-12 |
| AU2003208337A1 (en) | 2003-09-02 |
| DE50308787D1 (de) | 2008-01-24 |
| EP1474414B1 (fr) | 2007-12-12 |
| TW200404792A (en) | 2004-04-01 |
| CA2475093A1 (fr) | 2003-08-14 |
| CO5601008A2 (es) | 2006-01-31 |
| EP1474414A1 (fr) | 2004-11-10 |
| CN1630649A (zh) | 2005-06-22 |
| NO20043717L (no) | 2004-11-03 |
| ATE380805T1 (de) | 2007-12-15 |
| RU2306311C2 (ru) | 2007-09-20 |
| WO2003066620A1 (fr) | 2003-08-14 |
| ZA200406015B (en) | 2005-11-14 |
| BR0307495A (pt) | 2004-12-28 |
| MXPA04007476A (es) | 2004-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA27147A1 (fr) | 4-phenyltetrahydro-isoquinoleines substituees, procede pour leur preparation, leur utilisation en tant que medicament, et medicament les contenant | |
| MA26532A1 (fr) | Derives d'amines cycliques, compositions pharmaceutiques les contenant, procede pour les preparer, et leur utilisation et tant que principe pharmaceutique agissant contre les maladies respiratoires. | |
| WO2004075823A8 (fr) | Derives de benzimidazole et d’imidazo-pyridine ayant une addinite pour les recepteurs des melanocortines et leur utilisation en tant que medicament | |
| FR2906475B1 (fr) | Unite medicale pour le prelevement,le calibrage,la dilution et/ou l'injection d'un produit radioactif injectable | |
| ZA200506422B (en) | Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use of the same as medicaments, and medicament containing such compounds | |
| ATE450501T1 (de) | Pentafluorsulfanyl-substituierte verbindung und deren verwendung zur herstellung von arzneimitteln | |
| NO20062824L (no) | 1,3-Difenylprop-2-en-1-on-avledete forbindelser, fremgangsmater for fremstilling derav, samt anvendelse av samme | |
| FR2885129B1 (fr) | Nouveaux derives de l'ureee substituee parun thiazole ou benzothiazole, leur procede de preparation, leur application a titre de medicaments, les compositions pharmaceutiques les renfermant et utilisation. | |
| ATE478842T1 (de) | Ringsubstituierte diphenylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung | |
| BRPI0410611A (pt) | processo para a formação de um produto em bastão, sólido, antitranspirante ou desodorante, auto-suportado | |
| MA26785A1 (fr) | Nouveau produit pharmaceutique. | |
| NO20043252L (no) | Fremgangsmate for fremstilling av tissueprodukt inneholdende karboksylerte cellelosefibre | |
| BRPI0518790A2 (pt) | formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, produto, e, cÁpsula ou tablete | |
| HK1076460A1 (en) | Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same | |
| MA26786A1 (fr) | Nouveau produit pharmaceutique. | |
| FR2904217B1 (fr) | Melange d'esters partiels de monopentaerytritol, dipentaerytritol et tripentaerytritol, procede pour leur obtention et produit cosmetique en contenant | |
| PT1124841E (pt) | Fenil-alcenoil-guanidinas processo para a sua preparacao sua utilizacao como medicamentos ou meios de diagnostico bem como composicao farmaceutica que as contem | |
| MA27171A1 (fr) | Dihydro-thia-phenanthrene-darbonyl-guanidines, procede de production desdites substances et leur utilisation en tant que medicament ou produit de diagnostic, et medicament contenant lesdites substances | |
| FR2834643B1 (fr) | Composition pharmaceutique anti-depressive contenant un extrait de polygala et son procede de preparation | |
| MA28161A1 (fr) | Les pentafluorosulfanylbenzoylguanidines, leur procédé de production, leur utilisation comme médicaments ou agents de diagnostic et les médicaments les contenant | |
| WO2001020026A3 (fr) | Polymorphismes du gene humain hpxr et leur utilisation dans des applications diagnostiques et therapeutiques | |
| ATE405547T1 (de) | Amidomethyl-substituierte 2-(4-sulfonilamino)-3- hidroxy-3,4-dihydro- 2h-chromen-6-yl-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| ATE487741T1 (de) | Mischungen aus von heparin abgeleiteten oligosacchariden, herstellung davon und pharmazeutische zusammensetzungen, die die mischungen enthalten | |
| PT1097140E (pt) | Derivados de imidazole substituidos com bifenilsulfonilo processo para a sua preparacao sua aplicacao como medicamento ou meio de diagnostico asim como medicamento neles incluido | |
| BRPI0409793A (pt) | 4-,6- ou 7-hidroxiindóis com grupos n-óxido e sua aplicação como produtos terapêuticos |